CJ exclusively to distribute Tezalin, anti-rhinitis agent.

Published: 2004-07-16 06:56:00

Updated: 2004-07-16 06:56:00

CJ pharmaceutical division agreed with Zeller Co., a Swiss pharmaceutical company on July 12 for the exclusive distribution of Tezalin in Korea, a phytochemical drug for the treatment of rhinitis.

Tezalin was developed by Zeller Co., one of the top herbal pharmaceutical manufacturers in Switz...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK